<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25943" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Non&#x02013;ST-Segment Elevation Myocardial Infarction</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Basit</surname>
            <given-names>Hajira</given-names>
          </name>
          <aff>Brookdale University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Malik</surname>
            <given-names>Ahmad</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Huecker</surname>
            <given-names>Martin R.</given-names>
          </name>
          <aff>University of Louisville</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hajira Basit declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ahmad Malik declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Martin Huecker declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25943.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Acute coronary syndrome (ACS) can be divided into subgroups of ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), and unstable angina. ACS carries significant morbidity and mortality and prompt diagnosis, and appropriate treatment is essential. This activity highlights the role of the interprofessional team in caring for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of acute coronary syndrome.</p></list-item><list-item><p>Review the typical presentation of a patient with NSTEMI.</p></list-item><list-item><p>Summarize the treatment options for NSTEMI.</p></list-item><list-item><p>Explain the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by NSTEMI.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25943&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25943">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25943.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Acute coronary syndrome (ACS) can be divided into subgroups of ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), and unstable angina. ACS carries significant morbidity and mortality and the prompt diagnosis, and appropriate&#x000a0;treatment is essential. STEMI diagnosis and management are discussed elsewhere. NSTEMI and Unstable angina are very similar, with NSTEMI having positive cardiac biomarkers. The presentation, diagnosis, and management of NSTEMI are discussed below.<xref ref-type="bibr" rid="article-25943.r1">[1]</xref><xref ref-type="bibr" rid="article-25943.r2">[2]</xref><xref ref-type="bibr" rid="article-25943.r3">[3]</xref></p>
      </sec>
      <sec id="article-25943.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of NSTEMI varies as there are several potential causes. These include tobacco abuse, lack of physical activity, high blood pressure, high cholesterol, diabetes, obesity, and family history.</p>
      </sec>
      <sec id="article-25943.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The median age at the time of presentation for ACS in the United States is 68 years. Males outnumber females by a 3:2 ratio. The incidence of ACS in the United States is over 780,000, and of those, approximately 70% will have NSTEMI.</p>
      </sec>
      <sec id="article-25943.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>ACS&#x000a0;is simply&#x000a0;a mismatch in the myocardial oxygen demand and myocardial oxygen consumption. While the cause of this mismatch in STEMI is nearly always coronary plaque rupture resulting in thrombosis formation occluding a coronary artery, there are several potential causes of this mismatch in NSTEMI. There may be a flow-limiting condition such as a stable plaque, vasospasm as in Prinzmetal angina, coronary embolism, or coronary arteritis. Non-coronary injury to the heart such as cardiac contusion, myocarditis, or presence of cardiotoxic substances can also produce NSTEMI. Finally, conditions relatively unrelated to the coronary arteries or myocardium itself such as hypotension, hypertension, tachycardia, aortic stenosis, and pulmonary embolism lead to NSTEMI because the increased oxygen demand cannot be met.<xref ref-type="bibr" rid="article-25943.r4">[4]</xref><xref ref-type="bibr" rid="article-25943.r5">[5]</xref></p>
      </sec>
      <sec id="article-25943.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The &#x0201c;typical&#x0201d; presentation of NSTEMI is a pressure-like substernal pain, occurring at rest or with minimal exertion. The pain generally&#x000a0;lasts more than 10 minutes and may radiate to either arm, the neck, or the jaw.&#x000a0; The pain may be associated with dyspnea, nausea or vomiting, syncope, fatigue, or diaphoresis. Sudden onset of unexplained dyspnea with or without associated symptoms is also a common presentation. Risk factors for ACS include male sex, older age, family history of coronary artery disease, diabetes, personal history of coronary artery disease, and renal insufficiency. Atypical symptoms may include a stabbing or pleuritic pain, epigastric or abdominal pain, indigestion, and isolated dyspnea. While all patients presenting with ACS are more likely to present with typical symptoms than atypical symptoms, the likelihood of atypical presentations increases with age over 75, women and those with diabetes, renal insufficiency, and dementia. &#x000a0;</p>
        <p>Physical Exam for ACS and NSTEMI is often nonspecific. Clues such as back pain with aortic dissection or pericardial friction rub with pericarditis may point to an alternative diagnosis for a patient&#x02019;s chest pain, but no such exam finding exists that indicates ACS as the most likely diagnosis. Signs of heart failure should increase concern for ACS but are, again, nonspecific findings.<xref ref-type="bibr" rid="article-25943.r6">[6]</xref><xref ref-type="bibr" rid="article-25943.r7">[7]</xref><xref ref-type="bibr" rid="article-25943.r8">[8]</xref></p>
      </sec>
      <sec id="article-25943.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>History, ECG, and cardiac biomarkers are the mainstays in the evaluation. An ECG should be performed as soon as possible&#x000a0;in patients presenting with chest pain or those with a concern for ACS. A normal ECG does not exclude ACS and NSTEMI. ST-elevation or anterior ST depression should be considered a STEMI until proven otherwise and treated&#x000a0;as such. Findings suggestive of NSTEMI include transient ST elevation, ST depression, or new T wave inversions. ECG should be repeated at predetermined intervals or if symptoms return.</p>
        <p>Cardiac troponin is the cardiac biomarker of choice. Troponin is more specific and more sensitive than other biomarkers and becomes elevated relatively early in the disease process. While contemporary cardiac troponin may not be elevated within the first 2 to 4 hours after symptom onset, newer high sensitivity troponin assays have detectable elevations much earlier. It is also true that the amount of troponin released, and therefore the time to elevation, is proportional with infarct size, so it is unlikely to have a negative initial troponin with larger infarcts. Regardless of infarct size, most patients with true ischemia will have elevations in troponin within 6 hours, and negative troponins at this point effectively&#x000a0;rule out infarct in most patients.&#x000a0; Most assays use a cutoff value of greater than a 99th percentile as a positive test. In older, contemporary troponin assays, no detectable troponin is reported in most healthy individuals without the disease.&#x000a0; Newer high sensitivity troponin assays&#x000a0;often&#x000a0;will report a normal detectable range in healthy individuals without the disease.&#x000a0;</p>
        <p>Several tools and scores have been developed to assist in the workup of ACS. These tools must be used with caution and in the appropriate&#x000a0;context as none have been definitively shown to be superior to clinician judgment. Some common tools available are the TIMI (Thrombolysis In Myocardial Infarction) risk score, the GRACE (Global Registry of Acute Coronary Events) risk score, the Sanchis score, the Vancouver rule, HEART (History, ECG, Age, Risk Factors, and Troponin) score, HEARTS3 score, and Hess prediction rule. The&#x000a0;HEART&#x000a0;score was specifically developed for emergency department patients and has gained popularity in this setting.&#x000a0;</p>
        <p>
<bold>Diagnosis&#x000a0;</bold>
</p>
        <p>NSTEMI is diagnosed in patients determined to have symptoms consistent with ACS and troponin elevation but without ECG changes consistent with STEMI. Unstable angina and NSTEMI differ primarily in the presence or absence of detectable troponin leak.&#x000a0;</p>
      </sec>
      <sec id="article-25943.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Initial management strategies aim to reduce cardiac ischemia and prevent death. Oxygen, aspirin, and nitrates are administered based on initial concern for ACS and prior to a definitive diagnosis. Subsequent treatment depends on confirmation of diagnosis or a high index of suspicion with or without a definitive diagnosis.&#x000a0;<xref ref-type="bibr" rid="article-25943.r1">[1]</xref><xref ref-type="bibr" rid="article-25943.r9">[9]</xref><xref ref-type="bibr" rid="article-25943.r10">[10]</xref><xref ref-type="bibr" rid="article-25943.r11">[11]</xref><xref ref-type="bibr" rid="article-25943.r12">[12]</xref></p>
        <p>Oxygen was previously recommended for all patients presenting with concern for ACS, but newer data suggests this strategy may be harmful in patients who otherwise do not warrant supplemental oxygen. Supplemental oxygen is now recommended in patients with oxygen saturation less than 90%, those with respiratory distress, or when high-risk features of hypoxemia are present.&#x000a0;</p>
        <p>Chewable, non-coated, aspirin 324 mg should be given to all patients who present with concern for ACS unless otherwise contraindicated.&#x000a0; Patients who cannot take aspirin may be given prasugrel 60 mg PO.</p>
        <p>Patients with ongoing symptoms should receive 0.4 mg sublingual nitroglycerin every 5 minutes for up to three doses or until the pain is relieved, unless otherwise contraindicated. Contraindications include the recent use of phosphodiesterase inhibitors and hypotension.&#x000a0;Nitrates should be used with extreme caution in patients with concerns for right-sided infarction. Continuous intravenous nitroglycerin should be considered in patients with persistent signs of heart failure or hypertension.</p>
        <p>Many patients will present with concern for ACS but will not have positive findings of ischemic ECG changes or positive troponin on initial workup. These patients may be observed with serial ECG and troponin measurements every 3 to 6 hours. Patients&#x000a0;also&#x000a0;may undergo provocative testing such as the treadmill stress test or myocardial perfusion imaging prior to discharge or within 72 hours. Low-risk patients&#x000a0;often&#x000a0;may be discharged&#x000a0;with a referral for further outpatient testing&#x000a0;after initial ACS is ruled out.</p>
        <p>In patients where NSTEMI has been definitively diagnosed or is highly likely, anticoagulation should be initiated. Protocols will vary by institution, so cardiology consultation should be obtained if readily available.&#x000a0;This is especially true when there is the possibility of percutaneous intervention, as this may change anticoagulation strategies. Unfractionated heparin with bolus dosing and a continuous infusion is commonly used, with most institutions having protocols available. Other strategies may include the use of enoxaparin, bivalirudin, fondaparinux, and dual antiplatelet therapies. Fibrinolytic therapies should not be used in NSTEMI.&#x000a0;</p>
        <p>When NSTEMI has been diagnosed, patients should be admitted to cardiac care units for further management. Beta-blocker therapy should be started within 24 hours after the presentation in patients who do not have a contraindication. Contraindications include signs of heart failure, hypotension, heart conduction block, or reactive airway disease. Unless otherwise contraindicated,&#x000a0;ACE Inhibitors should be initiated in patients with an ejection fraction less than 40%, hypertension, diabetes, or chronic kidney disease. High-dose statins should be initiated for cholesterol management. Invasive and non-invasive testing strategies are employed. Both early intervention strategies with diagnostic angiography and intervention are applied as indicated, and conservative medical management strategies are employed. The rationale for choosing one strategy over the other is often patient and institution-specific and beyond the scope of&#x000a0;this review.</p>
      </sec>
      <sec id="article-25943.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Clinical conditions that can present with chest pain and have nonspecific ECG changes with an elevated troponin marker include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Myocarditis</p>
          </list-item>
          <list-item>
            <p>Pericarditis</p>
          </list-item>
          <list-item>
            <p>Pulmonary embolism</p>
          </list-item>
          <list-item>
            <p>Left ventricular aneurysm</p>
          </list-item>
          <list-item>
            <p>Prinzmetal angina</p>
          </list-item>
          <list-item>
            <p>Anxiety Disorder</p>
          </list-item>
          <list-item>
            <p>Aortic Stenosis</p>
          </list-item>
          <list-item>
            <p>Hypertensive emergency</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25943.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Patients who present with NSTEMI have a lower 6-month mortality rate than those who present with unstable angina. Morbidity and mortality further depend on the degree of troponin elevation as well as comorbid conditions such as the severity of diabetes, presence of peripheral vascular disease, presence of renal dysfunction, and dementia.<xref ref-type="bibr" rid="article-25943.r13">[13]</xref></p>
      </sec>
      <sec id="article-25943.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of NSTEMI are secondary to the systemic effects of the disease rather than structural complications of STEMI. Cardiomyopathy with diffuse hypokinesis may be seen but left ventricular aneurysms or papillary muscle dysfunction is rare. Pulmonary edema due to poor cardiac output may be seen in severe cases. Other complications of poor cardiac output such as renal dysfunction may be seen as well.<xref ref-type="bibr" rid="article-25943.r14">[14]</xref></p>
      </sec>
      <sec id="article-25943.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with NSTEMI need extensive counselling regarding medication compliance as well as lifestyle modifications to prevent repeat events and improve morbidity as well as mortality. Smoking cessation is essential. Smoking cessation counselling by the provider is recommended.&#x000a0;</p>
      </sec>
      <sec id="article-25943.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis and management of NSTEMI are best managed with an interprofessional team that consists of a cardiologist, internist, nurse practitioner, and a pharmacist.</p>
        <p>In patients where NSTEMI has been definitively diagnosed or is highly likely, anticoagulation should be initiated. Protocols will vary by institution, so cardiology consultation should be obtained if readily available.&#x000a0;This is especially true when there is the possibility of percutaneous intervention, as this may change anticoagulation strategies.&#x000a0;</p>
        <p>When NSTEMI has been diagnosed, patients should be admitted to cardiac care units for further management. Beta-blocker therapy should be started within 24 hours after the presentation in patients who do not have a contraindication. Unless otherwise contraindicated,&#x000a0;ACE Inhibitors should be initiated in patients with an ejection fraction of less than 40%, hypertension, diabetes, or chronic kidney disease. High-dose statins should be initiated for cholesterol management. Invasive and non-invasive testing strategies are employed. Both early intervention strategies with diagnostic angiography and intervention are applied as indicated, and conservative medical management strategies are employed.&#x000a0;</p>
        <p>The outcomes of patients with NSTEMI depend on the severity of the myocardial injury, compliance with treatment and other comorbidities. Patients who do not change their risk factors for the coronary disease have a poor outcome.<xref ref-type="bibr" rid="article-25943.r15">[15]</xref><xref ref-type="bibr" rid="article-25943.r16">[16]</xref> (Level V)</p>
      </sec>
      <sec id="article-25943.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25943&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25943">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/non-st-segment-elevation-myocardial-infarction-heart-attack-without-ecg-changes/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25943">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25943/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25943">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25943.s15">
        <title>References</title>
        <ref id="article-25943.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gilutz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shindel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shoham-Vardi</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Adherence to NSTEMI Guidelines in the Emergency Department: Regression to Reality.</article-title>
            <source>Crit Pathw Cardiol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-46</page-range>
            <pub-id pub-id-type="pmid">30747764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25943.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pi&#x00105;tek</surname>
                <given-names>&#x00141;</given-names>
              </name>
              <name>
                <surname>Wilczek</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Janion-Sadowska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gierlotka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>G&#x00105;sior</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sadowski</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Outcomes of a routine invasive strategy in elderly patients with non-ST-segment elevation myocardial infarction from 2005 to 2014: results from the PL-ACS registry.</article-title>
            <source>Coron Artery Dis</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>326</fpage>
            <page-range>326-331</page-range>
            <pub-id pub-id-type="pmid">30724817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25943.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manfredonia</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lanza</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Crudo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lamendola</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Graziani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Villano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Locorotondo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Melita</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mencarelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pennestr&#x000ec;</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lombardo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Vita</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ravenna</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Bisignani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Crea</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic role of echocardiography in patients admitted to the emergency room with suspect no-ST-segment elevation acute myocardial infarction.</article-title>
            <source>Eur Rev Med Pharmacol Sci</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>826</fpage>
            <page-range>826-832</page-range>
            <pub-id pub-id-type="pmid">30720191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25943.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rupprecht</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Geeren</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Geeren</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weilemann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schuster</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>[Acute coronary syndrome without ST-elevation (NSTE-ACS)].</article-title>
            <source>Herz</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-15</page-range>
            <pub-id pub-id-type="pmid">30627742</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25943.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kami&#x00144;ska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Koper</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Siedlecka-Czykier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Matowicka-Karna</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bychowski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kemona</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The utility of inflammation and platelet biomarkers in patients with acute coronary syndromes.</article-title>
            <source>Saudi J Biol Sci</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>25</volume>
            <issue>7</issue>
            <fpage>1263</fpage>
            <page-range>1263-1271</page-range>
            <pub-id pub-id-type="pmid">30505168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25943.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sriha Belguith</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Beltaief</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Msolli</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Bouida</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Abroug</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ben Fredj</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zemni</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Grissa</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Boubaker</surname>
                <given-names>H</given-names>
              </name>
              <collab>ESCor Investigators group</collab>
              <name>
                <surname>Hsairi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nouira</surname>
                <given-names>S</given-names>
              </name>
              <collab>ESCorT Investigators group</collab>
            </person-group>
            <article-title>Management of acute coronary syndrome in emergency departments: a cross sectional multicenter study (Tunisia).</article-title>
            <source>BMC Emerg Med</source>
            <year>2018</year>
            <month>Dec</month>
            <day>03</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>50</fpage>
            <pub-id pub-id-type="pmid">30509187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25943.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lemkes</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Janssens</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>van der Hoeven</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>van de Ven</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Marques</surname>
                <given-names>KMJ</given-names>
              </name>
              <name>
                <surname>Nap</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Leeuwen</surname>
                <given-names>MAH</given-names>
              </name>
              <name>
                <surname>Appelman</surname>
                <given-names>YEA</given-names>
              </name>
              <name>
                <surname>Knaapen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Verouden</surname>
                <given-names>NJW</given-names>
              </name>
              <name>
                <surname>Allaart</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Brinckman</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Saraber</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Plomp</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Timmer</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Kedhi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hermanides</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Meuwissen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schaap</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van der Weerdt</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>van Rossum</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Nijveldt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>van Royen</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial.</article-title>
            <source>Eur Heart J</source>
            <year>2019</year>
            <month>Jan</month>
            <day>14</day>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>283</fpage>
            <page-range>283-291</page-range>
            <pub-id pub-id-type="pmid">30371767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25943.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arora</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stouffer</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Kucharska-Newton</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vaduganathan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Qamar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Matsushita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kolte</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Bangalore</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rosamond</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Bhatt</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Caughey</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Fifteen-Year Trends in Management and Outcomes of Non-ST-Segment-Elevation Myocardial Infarction Among Black and White Patients: The ARIC Community Surveillance Study, 2000-2014.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2018</year>
            <month>Oct</month>
            <day>02</day>
            <volume>7</volume>
            <issue>19</issue>
            <fpage>e010203</fpage>
            <pub-id pub-id-type="pmid">30371336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25943.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Puymirat</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bonaca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fumery</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tea</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Aissaoui</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lemesles</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bonello</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ducrocq</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cayla</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ferri&#x000e8;res</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schiele</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Danchin</surname>
                <given-names>N</given-names>
              </name>
              <collab>FAST-MI investigators</collab>
            </person-group>
            <article-title>Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non-ST Elevation Myocardial Infarction registries.</article-title>
            <source>Clin Cardiol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>42</volume>
            <issue>2</issue>
            <fpage>227</fpage>
            <page-range>227-234</page-range>
            <pub-id pub-id-type="pmid">30536449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25943.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>G&#x000fc;ntekin</surname>
                <given-names>&#x000dc;</given-names>
              </name>
              <name>
                <surname>Tosun</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kilin&#x000e7;</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Saydam</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Korucuk</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bozdemir</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>ST segment elevation myocardial infarction (STEMI) patients are more likely to achieve lipid-lowering treatment goals: A retrospective analysis of patients presenting with first acute coronary syndromes.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>97</volume>
            <issue>39</issue>
            <fpage>e12225</fpage>
            <pub-id pub-id-type="pmid">30278492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25943.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanchis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ariza-Sol&#x000e9;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abu-Assi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Alegre</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Alfonso</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Barrab&#x000e9;s</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Baz</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Carol</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>D&#x000ed;ez Villanueva</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a Del Blanco</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>El&#x000ed;zaga</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fernandez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a Del Egido</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a Picard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez Bl&#x000e1;zquez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez Hospital</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez-Antol&#x000ed;n</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Llibre</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mar&#x000ed;n</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed; S&#x000e1;nchez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;n</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez Sell&#x000e9;s</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mi&#x000f1;ana</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Morales Gallardo</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>N&#x000fa;&#x000f1;ez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez de Prado</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pinar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sanmart&#x000ed;n</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sionis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Villa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marrugat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bueno</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design.</article-title>
            <source>Rev Esp Cardiol (Engl Ed)</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>72</volume>
            <issue>2</issue>
            <fpage>154</fpage>
            <page-range>154-159</page-range>
            <pub-id pub-id-type="pmid">29525724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25943.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>B&#x000f8;naa</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Steigen</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Coronary angiography in non-ST-elevation acute myocardial infarction - whom and when?</article-title>
            <source>Tidsskr Nor Laegeforen</source>
            <year>2017</year>
            <month>Nov</month>
            <day>28</day>
            <volume>137</volume>
            <issue>22</issue>
            <pub-id pub-id-type="pmid">29181952</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25943.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanchis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>N&#x000fa;&#x000f1;ez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bod&#x000ed;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>N&#x000fa;&#x000f1;ez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Alvarez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bonanad</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Regueiro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bosch</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Heras</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sala</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bielsa</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ll&#x000e1;cer</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>86</volume>
            <issue>4</issue>
            <fpage>291</fpage>
            <page-range>291-6</page-range>
            <pub-id pub-id-type="pmid">21346247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25943.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elbadawi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Elgendy</surname>
                <given-names>IY</given-names>
              </name>
              <name>
                <surname>Mahmoud</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Barakat</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Mentias</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mohamed</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Ogunbayo</surname>
                <given-names>GO</given-names>
              </name>
              <name>
                <surname>Megaly</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Omer</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Paniagua</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Abbott</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Jneid</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Temporal Trends and Outcomes of Mechanical Complications in Patients With Acute&#x000a0;Myocardial Infarction.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2019</year>
            <month>Sep</month>
            <day>23</day>
            <volume>12</volume>
            <issue>18</issue>
            <fpage>1825</fpage>
            <page-range>1825-1836</page-range>
            <pub-id pub-id-type="pmid">31537282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25943.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harrington</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Stueben</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lenahan</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction: Medical and Surgical Interventions.</article-title>
            <source>Crit Care Nurs Clin North Am</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-64</page-range>
            <pub-id pub-id-type="pmid">30736935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25943.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Held</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>TD</given-names>
              </name>
            </person-group>
            <article-title>When small vessels become big problems! Microvascular dysfunction in NSTEMI.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2018</year>
            <month>Nov</month>
            <day>15</day>
            <volume>92</volume>
            <issue>6</issue>
            <fpage>1075</fpage>
            <page-range>1075-1076</page-range>
            <pub-id pub-id-type="pmid">30478884</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
